The American Association for Cancer Research (AACR) has announced the 2020–2021 class of U.S. Food and Drug Administration (FDA)-AACR Oncology Educational Fellows. This is the first year of the fellowship, a joint initiative of the Oncology Center of Excellence at the FDA and the AACR.
Margaret Foti, PhD, MD (hc)
The FDA-AACR Oncology Educational Fellowship is designed to promote scientific progress through the exchange of knowledge in oncology education, collaborative learning, and research. Through targeted educational activities and interactions with experts from the FDA Oncology Center of Excellence and the AACR, the fellows will increase their familiarity and experience with oncology drug development and the regulatory review process. The 20 fellows in this year’s class are hematology/oncology fellows and early-career cancer investigators at centers across the United States and Canada, selected through a competitive application process.
“The AACR is very proud to partner with Dr. Pazdur and his exceptional team at the FDA’s Oncology Center of Excellence on the FDA-AACR Oncology Educational Fellowship program,” said Margaret Foti, PhD, MD (hc), Chief Executive Officer of the AACR. “This exciting project will provide 20 talented young researchers and physician-scientists with a unique opportunity to more fully appreciate how regulatory science informs the way in which new cancer medicines are evaluated for their safety and efficacy.”
The 2020–2021 FDA-AACR Oncology Educational Fellows are: